Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide

6

By Robin Respaut SAN FRANCISCO, Aug 12 (Reuters) – Eli Lilly on Wednesday said it had filed six lawsuits against U.S. companies it accuses of illegally selling black-market versions of its

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)